Evidence map›Paper›PMID 36459962›Full record

ArticleCell stem cell2022

Specialized cells for building tissue bridges.

April M Craft, Jenna Galloway

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cell stem cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

April M CraftDepartment of Orthopedic Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Stem Cells & Regenerative Biology, Harvard University, Cambridge, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA. Electronic address: april.craft@childrens.harvard.edu.
Jenna GallowayHarvard Stem Cell Institute, Cambridge, MA, USA; Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.

Funding

Tendon Enthesis Development and RegenerationR01AR055580 · NIAMS · WASHINGTON UNIVERSITY · PI THOMOPOULOS, STAVROS · 2009 to 2019
$4.0M
NIAMS NIH HHS R01 AR055580
6 · The paper itself

Abstract

Fang and colleagues provide a comprehensive transcriptomic analysis of the cell types occupying the interface between tendon and bone, the enthesis. They establish a framework for understanding enthesis maturation and identify a potent Gli1-lineage progenitor with clonogenicity and multipotency that improves enthesis healing in an adult injury model.

Indexed as

Gene Expression ProfilingWound HealingAdultHumans

Identifiers

PMID36459962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.